surgical management of
play

Surgical Management of Introduction, Definitions & - PowerPoint PPT Presentation

Outline Surgical Management of Introduction, Definitions & Nomenclature Severe Acute Pancreatitis Management Controversies & Current Literature UCSF Case Series Summary UCSF Postgraduate Course in General Surgery


  1. Outline Surgical Management of • Introduction, Definitions & Nomenclature Severe Acute Pancreatitis • Management Controversies & Current Literature • UCSF Case Series • Summary UCSF Postgraduate Course in General Surgery San Francisco, CA May 17, 2013 Hobart W. Harris, MD, MPH University of California, San Francisco Diagnosis Severe Acute Pancreatitis (SAP) • Clinical Presentation • Pancreatitis in the context of acute organ dysfunction; – Acute upper abdominal pain radiating to the back – Nausea and Vomitting • Ranson score ≥ 3 at 48 h – Low grade fever – mild tachypnea/tachycardia • APACHE II score ≥ 8 – epigastric tenderness ± mass • Multiple organ dysfunction score >3 at 72 h • Laboratory Values – Elevated pancreatic enzymes – CRP

  2. Nomenclature Controversies in Management Atlanta Classification (1992) – Arch Surg 1993;128:586-590 1. Acute fluid collections • Indications for Intervention 2. Pancreatic necrosis 3. Pseudocyst • Optimal Timing 4. Pancreatic abscess • Recommended Surgical Approach Acute Pancreatitis Classification Working Group (2008) – www.pancreasclub.com/Atlanta-Classification 1. Acute peripancreatic fluid collections 2. Acute post-necrotic pancreatic/peripancreatic fluid collections 3. Pseudocysts 4. Walled-off pancreatic necrosis Critical issues: age of the fluid collection ( ≥ 4 weeks); necrosis present correlates collection type to treatment recommendation Dutch Prospective Multi-Center Observational Cohort Study Treatment Outcomes in Patients with Necrotizing Pancreatitis (N=639, 2004-2008)

  3. Indications for Surgery • Infected Pancreatic Necrosis with Organ Failure - Level III evidence (Grade B Recommendation) • However: Text - 50% of mortalities were in patients with sterile necrosis - Overall mortality with conservative treatment: 7% (28/397) - 16% had organ failure � 37% mortality - 3% had infected necrosis � 0% mortality • Infection, Instability and Intransigence 10 5 Optimal Timing Optimal Timing • Dutch study favors delaying intervention and when possible for at least 4 weeks - Level III evidence (Grade B recommendations) • However: - lack of randomization confounds interpretation of this conclusion Text - data are not corrected for actual start of illness - 50% who underwent an intervention were transferred from another hospital • When the patient is medically optimized Mortality 56% 26% 15% <.001 Gastroenterology 2011;141:1254-1263

  4. Surgical Approach N Engl J Med 2010;362:1491-1502 Dutch Multi-Center RCT n = 88 with Infected Pancreatic Necrosis Randomized to Open Necrosectomy or “Step-up” approach Step-up approach was associated with fewer complications (40% vs 69% p=0.006); - 35% of patients in Step-up group were treated with drainage only - 7% of patients in Step-up group required Open Necrosectomy - Mortality did not differ between the two groups (19 vs 16% p=0.70) Surgical Approach Recommended Surgical Approach Blunt Necrosectomy & Reptroperitoneal “ Marsupialization ” • Minimally Invasive Approach - Step-up approach supperior to Open Necrosectomy (40% vs 69%, p-0.006) • Technically straightforward - 35% of patients in Step-up group were treated with drainage only - 7% of patients in Step-up group required Open Necrosectomy • Well-tolerated by critically-ill patients - Mortaity did not differ between the two groups (19 vs 16%, p=0.70) - Level Ib evidence! These data need to be confirmed • Avoids sacrifice of viable pancreas • However: • Enables spontaneous drainage & access for debridement of evolving - Requires strong IR support (frequency of manipulations & access) retroperitoneal necrosis while limiting intra-peritoneal trauma - Decreased composite complication score with MIS - No difference in mortality compared to open necrosectomy • Acceptable complication rates • Blunt Necrosectomy with Retroperitoneal Marsupialization • Reduction in mortality

  5. Case Presentation past 2 days following a “ big night ” on the town. Intermittent N/V, anorexia. 38M c/o acute onset severe RUQ & epigastric pain radiating to his back, for the PMHx Unremarkable. No Meds or PSH PE: T = 39.2 o C, anicteric, distended abdomen, tender epigastrium. Labs: WBC = 19K, Hct 57%, Amylase 343, ALT 417, Glucose 260, BMP & LDH WNL, Base Deficit -14. KUB: Adynamic Ileus, No free air or calcifications. Initial conservative management HD # 7 underwent exploratory laparotomy due to spiking fevers, abdominal distention and tenderness clinical instability and concern for infected necrosis.

  6. Demographics UCSF Experience Age 48 years • Retrospective review evaluating outcomes of the surgical (range 20-79 years) management of necrotizing pancreatitis Gender 63% male Ethnicity • 1994-2012 Hispanic 38% White 41% • 59 patients with CT-documented necrosis African-American 9% Asian 12% • Combined county and tertiary hospital experiences of a single surgeon Idiopathic (19%) Other Gallstones (9%) (30%) Alcohol (44%) Severity Assessment Indications for Surgery • Ranson Score (0-11; 19/59): 5.2 + 2.0 • Evidence of infection or sepsis: 44% - Pre-operative CT-guided FNA • Balthazar CT Score (1-10; 59/59): 7.3 + 2.8 - 42% (25/59) had a score of 10 • Clinical instability: 18% - persistent/recurrent hypotension - worsening respiratory function - worsening acidosis >50% Necrosis (62%) • Clinical intransigence: 44% 0% Necrosis (2%) - failed repeated attempts to wean off vasopressors and/or mechanical ventilation <30% Necrosis (26%) - Inability to tolerate an oral diet 30-50% Necrosis (10%)

  7. Outcomes Summary Outcomes Summary Necrosectomies (#) 3 (range 1-15) Morbidity ARDS (29%) Time from Diagnosis to OR 60 days (range 5-150) Sepsis (27%) Time from Admission to OR 15 days Fistulas (24%) (range 0-65) AKI (17%) Infected Necrosis 57% Incisional hernia (5%) Abscess (3%) Antibiotics (# used) 4 Endocrine/Exocrine Dysfunction Insulin (37%) (range 0-17) Enzymes (12%) TPN administration 27 days (range 0-111) Mortality 7% ICU LOS 31 ± 41 days Hospital LOS 61 ± 52 days Summary • Severe acute pancreatitis remains a complex, lethal condition; • Objective severity assessment is critical to optimal management; • The patient’s clinical condition should dictate surgical intervention; • Minimally invasive surgical techniques have extended the interventional armamentarium; • Blunt necrosectomy remains a safe and effective surgical approach.

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend